Michael Vigilante
Directeur/Membre du Conseil chez Corium LLC
Profil
Mr. Michael Vigilante is an Analyst at Gurnet Point Capital.
Prior to joining Gurnet Point Capital in 2014, Mr. Vigilante was an analyst in the investment banking group of MTS Health Partners.
Mr. Vigilante graduated from University of Pennsylvania, and holds a BS from the Wharton School of Business and a BA in Biology.
Postes actifs de Michael Vigilante
| Sociétés | Poste | Début |
|---|---|---|
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts. | Analyste en capital-investissement | 01/01/2014 |
Corium LLC
 Corium LLC BiotechnologyHealth Technology Corium LLC is a commercial-stage biopharmaceutical company that specializes in developing and commercializing novel neuroscience therapies. Corium is based in Grand Rapid, MI, and the CEO of the private company is Perry J. Sternberg. The company provides clinicians with important treatment options for patients, their families, and their caregivers. | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Vigilante
| Sociétés | Poste | Fin |
|---|---|---|
| MTS Health Partners GP LLC | Corporate Officer/Principal | 31/12/2013 |
Formation de Michael Vigilante
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
| MTS Health Partners GP LLC | |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Corium LLC
Corium LLC BiotechnologyHealth Technology Corium LLC is a commercial-stage biopharmaceutical company that specializes in developing and commercializing novel neuroscience therapies. Corium is based in Grand Rapid, MI, and the CEO of the private company is Perry J. Sternberg. The company provides clinicians with important treatment options for patients, their families, and their caregivers. | Health Technology |
